Video: Ethical and regulatory use of biospecimens in the EU
Posted: 1 July 2019 | BioIVT | No comments yet
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
The procurement and use of human biospecimens for life science researchers is complex and challenging, with involvement of regional, country and higher authorities. Register for this webinar and learn the unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union and the United Kingdom. Developed specifically for regulatory personnel and all levels of researchers in Europe to gain insight and guidance.
Watch this webinar to learn:
- Views surrounding compensation vs reimbursement
- Different types and uses of non-consented samples (ie, remnant or waiver of consent)
- Requirements to ensure the ethical collection and use of non-US samples
- How BioIVT ensures industry-leading best practices
- How BioIVT works with you to ensure regulatory oversight.
Related topics
Assays, Drug Discovery Processes, Genomics, Informatics, Legal & Compliance, Screening, Sequencing, Stem Cells, Translational Science
Related organisations
BioIVT
